CLCR Calls 2021 Archive

December 27, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Potential Increase in Testing Demand
    Henry Walke, CDC Center for Preparedness and Response (CPR)
  • SARS-CoV-2 Variants Update
    John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • FDA Update
    Tim Stenzel, US Food and Drug Administration (FDA)
  • LOINC In Vitro Diagnostic (LIVD) Test Code Mapping Tool
    MariBeth Gagnon, CDC Division of Laboratory Systems (DLS)

December 27, 2021 Meeting Materials

Transcript »

Slides »


December 13, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Resources for Accurate and Reliable COVID-19 Testing at CLIA Certificate of Waiver Sites
    Nancy Anderson, CDC Division of Laboratory Systems
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)
  • SARS-CoV-2 Variants Update
    John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

December 13, 2021 Meeting Materials

Transcript »

Slides »


November 15, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Introduction to Laboratory Risk Management (LRM) and Biological Risk Management for Point-of-Care Testing Sites
    Sabrina Debose, CDC Division of Laboratory Systems (DLS)
  • Virtual Reality (VR) Laboratory Training Demo
    Joe Rothschild, CDC Division of Laboratory Systems

November 15, 2021 Meeting Materials

Transcript »

Slides »


November 1, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Successful Mitigation of SARS-CoV-2 Transmission at a Residential Secondary School
    Kevin Volpp and Bruce Kraut, University of Pennsylvania
  • SARS-CoV-2 Variants Update
    John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

November 01, 2021 Meeting Materials

Transcript »

Slides »


October 18, 2021
Agenda
  • Welcome
    • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Say Yes to COVID-19 Testing (SYCT) Initiative Overview
    • Matthew McMahon & Rachael Fleurence, National Institutes of Health (NIH)
  • COVID-19 Testing and Policy in Utah K–12 Schools
    • William Lanier, Utah Department of Health
  • CMS Update
    • Felicidad (Faye) Valcarcel, Centers for Medicare and Medicaid Services (CMS)
  • SARS-CoV-2 Variants Update
    • John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response

October 18, 2021 Meeting Materials

Transcript »

Slides »


October 4, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Daily Testing vs. Self-Isolation for School Based COVID-19 Contacts
    Bernadette Young, University of Oxford
  • “Test to Stay” Studies
    Ebony Thomas, CDC State, Tribal, Local, and Territorial Support Task Force
  • CMS Update
    Felicidad Valcarcel, Centers for Medicare and Medicaid Services (CMS)
  • FDA Update
    Toby Lowe, U.S. Food and Drug Administration (FDA)

October 04, 2021 Meeting Materials

Transcript »

Slides »


September 20, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • SARS-CoV-2 Variants Update
    John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • Flu Testing Guidance
    Manish Patel, CDC Influenza Division
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)

September 20, 2021 Meeting Materials

Transcript »

Slides »


August 23, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • SARS-CoV-2 Variants Update
    John Barnes, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • Testing and Diagnostics Workgroup Update
    Dean Winslow, U.S. Department of Health and Human Services (HHS) Testing and Diagnostics Workgroup
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)

August 23, 2021 Meeting Materials

Transcript »

Slides »


August 9, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Use of Cycle Threshold (Ct) Values 
    Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • SARS-CoV-2 Variants Update
    Jessica Chen, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • RADx Update
    Bruce Tromberg, National Institutes of Health (NIH) RADx
  • Abbott BinaxNOW and Emerging Variants
    Wilbur Lam, Joshua Levy, Jennifer Frediani, and Anuradha Rao, Emory University

August 09, 2021 Meeting Materials

Transcript »

Slides »


July 26, 2021
Agenda
  • Welcome
    Nancy Anderson, CDC Division of Laboratory Systems (DLS)
  • CDC Influenza SARS-CoV-2 Multiplex Assay
    Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • Genomic Changes Causing SARS-CoV-2 Detection Partial Failure
    Daniel D. Rhoads, Cleveland Clinic
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)

July 12, 2021 Meeting Materials

Transcript »

Slides »


June 28, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Public Health Laboratory Support of Point-of-Care Testing Sites
    Sanjib Bhattacharyya, City of Milwaukee Health Department
  • Over-the-Counter Tests and CLIA
    Amy Zale, Centers for Medicare & Medicaid Services

June 28, 2021 Meeting Materials

Transcript »

Slides »


June 14, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • SARS-CoV-2 Variants Update
    Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • National Wastewater Surveillance System
    Amy Kirby, CDC Division of Foodborne, Waterborne, and Environmental Diseases (DFWED)
  • Sodium Citrate Tubes Supply Shortage
    Tammy Beckham and Linda Ricci, U.S. Food and Drug Administration (FDA)
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)
  • COVID-19 Viral Testing Tool Demo
    Muktha Natrajan, CDC Division of Laboratory Systems

June 14, 2021 Meeting Materials

Transcript »

Slides »


May 17, 2021
Agenda
  • Welcome
    Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
  • Antigen Testing Guidance
    Muktha Natrajan, CDC Division of Laboratory Systems (DLS)
  • Biosafety Guidance Update
    Aufra C. Araujo, CDC Division of Laboratory Systems (DLS)
  • SARS-CoV-2 Variants Update
    Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response
  • How the Federal Government is Addressing Laboratory Supply Issues
    Steven Santos, HHS Testing and Diagnostics Workgroup
    Matthew Hubbard, HHS Testing and Diagnostics Workgroup
  • FDA Update
    Tim Stenzel, U.S. Food and Drug Administration (FDA)

May 17, 2021 Meeting Materials

Transcript »

Slides »


April 5, 2021
Agenda

Welcome

  • Nancy Anderson, CDC Division of Laboratory Systems (DLS)

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing

  • Richard Creager, NIH RADx Variant Task Force

Saliva-Based SARS-CoV-2 Testing Data

  • Anne Wyllie, Yale University

FDA Update

Tim Stenzel, U.S. Food and Drug Administration (FDA)

April 5, 2021 Meeting Materials

Transcript »

Slides »


March 8, 2021
Agenda

Welcome

  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

SARS-CoV-2 Variants Update

  • Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response

Updates from the CDC Infectious Diseases Pathology Branch

  • Julu Bhatnagar, CDC Division of High-Consequence Pathogens and Pathology (DCHPP)

FDA Update

Tim Stenzel, U.S. Food and Drug Administration (FDA)

March 8, 2021 Meeting Materials

Transcript »

Slides »


February 22, 2021
Agenda

Welcome 

  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

K-12 Testing Guidance

  • Greta Massetti, CDC Community Interventions and Critical Populations Task Force for the COVID-19 Response

SARS-CoV-2 Variants Update 

  • Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response 

CDC Testing Order for Air Passengers 

  • Nicky Cohen, CDC Global Migration Task Force for the COVID-19 Response 
  • Pam Diaz, CDC Global Migration Task Force for the COVID-19 Response

FDA Update

    • Tim Stenzel, U.S. Food and Drug Administration (FDA) 

February 22, 2021 Meeting Materials

Transcript »

Slides »


February 8, 2021
Agenda

Welcome

  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

CDC Virtual Reality Laboratory Training Course

  • Joe Rothschild, CDC Division of Laboratory Systems (DLS)

Sequencing Efforts of Public Health Laboratories

  • Heather Blankenship and Marty Soehnlen, Michigan Department of Health and Human Services

SARS-CoV-2 Variants Update

  • Vivien Dugan, CDC Laboratory and Testing Task Foce for the COVID-19 Response

Vaccine Breakthrough Case Investigations

  • Leisha Nolen, CDC COVID-19 Response Vaccine Breakthrough Team

FDA Update

  • Tim Stenzel, U.S. Food and Drug Administration (FDA)

February 8, 2021 Meeting Materials

Transcript »

Slides »


January 25, 2021
Agenda

Welcome

  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

What Are the Clinical Laboratory Result Abnormalities in Patients Hospitalized with COVID-19?

  • Nadia Ayala-Lopez, Johns Hopkins Medical Institute

COVID-19 Variants and Surveillance

  • Chris Elkins, CDC COVID-19 Laboratory and Testing Task Force

CMS Billing Update

  • Sarah Harding, Centers for Medicare & Medicaid Services (CMS)

FDA Update

  • Tim Stenzel, U.S. Food and Drug Administration (FDA)

January 25, 2021 Meeting Materials

Transcript »

Slides »


January 11, 2021
Agenda

Welcome

  • Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

OneLab Network Overview

  • Senia Wilkins, CDC Division of Laboratory Systems (DLS)

Preliminary Data from BinaxNOW Antigen Testing

  • Jessica Prince Guerra, CDC Laboratory and Testing Task Force

Vaccine Effect on Serology Testing

  • Natalie Thornburg, CDC Laboratory and Testing Task Force

Surveillance Testing for non-CLIA Pop-up Labs

  • Amy Zale, Centers for Medicare & Medicaid Services (CMS)

FDA Update

  • Tim Stenzel, U.S. Food and Drug Administration (FDA)

January 11, 2021 Meeting Materials

Transcript »

Slides »